CrowdStreet’s Life Science Roundtable

by Cyrus Maunakea

Open for Investment

Parkside at Littleton Village is a Multifamily real estate investment opportunity offered on the CrowdStreet Marketplace

Acquisition of a 2022-constructed, stabilized, 114-unit multifamily asset in Littleton, CO, by repeat CS Sponsor, Brixton Capital, seeking to implement a multifaceted business plan to potentially drive NOI growth.

Multifamily Core-Plus

In our latest Life Sciences roundtable, CrowdStreet’s Investment Product & Portfolio Manager Thomas McDonald hosted a discussion with Cabot, Cabot, and Forbes CEO Jay Doherty and Jumbo Capital Management Co-founder and Managing Partner Jay Hirsh. The group discussed the growth of the life sciences market and what investors can expect in the future. Some highlights from the roundtable included:

The latest news of a huge player in the CRE market acquiring a massive portfolio of life science space
The types of companies driving demand for life science-related properties
Where to find the top life science hubs in the U.S.
The unique requirements of tenants in this space and how that impacts development
How some firms are repositioning existing properties to produce more supply in the most desired and constrained markets
How sectors like pharmaceuticals, scientific research, and robotics continue to drive this industry forward.